4.4 • 1K Ratings
🗓️ 17 March 2020
⏱️ 26 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | This is Exchanges at Goldman Sachs, where we discuss developments currently shaping markets, industries, and the global economy. |
0:15.0 | I'm Jake Seawert, Global Head of Corporate Communications here at the firm. |
0:18.0 | Today we'll be talking to Dr. Michael Rendell, Goldman Sachs' very own global medical director, about how a firm like |
0:24.8 | ours responds to the coronavirus pandemic, and what we all can be doing on the individual |
0:30.0 | level, including tips for staying in good shape mentally, physically as more of us |
0:34.4 | start working from home. Dr. Rendell, welcome to the program. |
0:37.3 | Thanks for having me. |
0:38.3 | Happy to be here. |
0:39.3 | Dr. Rendell, before we get to your role specifically at Goldman and how you prepare the firm for a health |
0:45.8 | crisis like this, let's talk a little bit about some of the most common questions we're getting |
0:50.2 | from our clients and others about the course of the pandemic and the specific |
0:55.9 | challenges unique challenges it raises for health care professionals and |
1:00.0 | and everyone really who's dealing with its consequences. |
1:03.4 | So how would you describe the state of testing? |
1:07.6 | You know, it's different region by region, but maybe start with the US. |
1:11.5 | Why has it been so hard to get people tested and why have the |
1:14.5 | protocols varied so widely in region or region? |
1:16.8 | All right, so let's start with the US. Unfortunately in the US, the testing kits |
1:21.2 | at the CDC were developing and manufacturing ended up being |
1:25.2 | faulty so they had to sort of scrap all these kits that they had and then start all |
1:29.2 | over again and so because of that we got behind and having enough testing kits that we anticipated we would need if when the coronavirus reached the US. |
1:38.0 | We've been ramping that up and and I think key to also that is being allowing commercial labs like |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Goldman Sachs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Goldman Sachs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.